RealFeedApp beta
- Researchers found a link between GLP-1 and biological age
Findings from Eli Lilly and Novo Nordisk show that overweight and diabetic patients using GLP-1s have a biological age two to three years younger than placebo users.
- Field
- ageing and longevity
- What they did
- Research shows that overweight and diabetic people taking GLP-1 drugs have a biological age 2–3 years younger than those taking a placebo.
- Why it matters
- This could be useful for understanding how these drugs affect aging, although their use is currently limited to people who are overweight or diabetic.
#glp-1#biological age#longevity#diabetes#weight loss
